Special Issue "Angiogenesis Inhibitors"

Quicklinks

A special issue of Pharmaceuticals (ISSN 1424-8247).

Deadline for manuscript submissions: closed (30 April 2011)

Special Issue Editor

Guest Editor
Prof. Dr. Domenico Ribatti
Dipartimento di Scienze Mediche di Base,Sezione di Anatomia Umana e Istologia, Università degli Studi di Bari, Piazza G. Cesare 11, Policlinico, 70124 Bari, Italy
E-Mail: ribatti@anatomia.uniba.it
Phone: +39 080 5478240
Fax: +39 080 5478310

Special Issue Information

Dear Colleagues,

The idea of targeting angiogenesis to inhibit tumor growth was proposed more than three decades ago by Judah Folkman, and since then several approaches to block or disrupt tumor angiogenesis have been explored.

Antiangiogenesis remains a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials.

Until now, the success of antiangiogenic compounds in the clinic is rather limited when given as monotherapies. This is in contrast with many preclinical results which revealed a much higher efficacy of these agents in animal models.

Prof. Dr. Domenico Ribatti
Guest Editor

Keywords

  • angiopoietin-2 antagonists
  • antiangiogenic monoclonal antibodies
  • assays to validate antiangiogenic agents
  • avastin
  • biomarkers of response to antiangiogenic therapy
  • combination of antiangiogenic therapy with other anticancer therapies
  • endogenous inhibitors of angiogenesis
  • genetic strategies for targeting angiogenesis
  • imaging of tumor angiogenesis
  • integrins as targets for antiangiogenic therapy
  • metronomic low-dose antiangiogenic chemotherapy
  • protein tyrosine kinase inhibitors
  • targeted drug delivery to the tumor neovasculature
  • thalidomide and its IMiD derivatives
  • translating angiogenesis inhibitors to the clinic

Published Papers (8 papers)

Download All Papers
Sort by:
Display options:
Select articles Export citation of selected articles as:
Select/unselect all
Displaying article 1-8
p. 1551-1577
by  and
Pharmaceuticals 2011, 4(12), 1551-1577; doi:10.3390/ph4121551
Received: 14 October 2011; in revised form: 24 November 2011 / Accepted: 25 November 2011 / Published: 2 December 2011
Show/Hide Abstract | Cited by 2 | PDF Full-text (789 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
p. 1052-1069
by , , , , , , ,  and
Pharmaceuticals 2011, 4(7), 1052-1069; doi:10.3390/ph4071052
Received: 29 April 2011; in revised form: 6 July 2011 / Accepted: 19 July 2011 / Published: 20 July 2011
Show/Hide Abstract | Cited by 2 | PDF Full-text (476 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
p. 782-793
by , ,  and
Pharmaceuticals 2011, 4(6), 782-793; doi:10.3390/ph4060782
Received: 25 April 2011; in revised form: 23 May 2011 / Accepted: 30 May 2011 / Published: 31 May 2011
Show/Hide Abstract | Cited by 1 | PDF Full-text (369 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
p. 3021-3039
by ,  and
Pharmaceuticals 2010, 3(10), 3021-3039; doi:10.3390/ph3103021
Received: 10 August 2010; in revised form: 19 September 2010 / Accepted: 25 September 2010 / Published: 28 September 2010
Show/Hide Abstract | Cited by 3 | PDF Full-text (404 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
abstract graphic
p. 1241-1278
by , , ,  and
Pharmaceuticals 2010, 3(4), 1241-1278; doi:10.3390/ph3041241
Received: 14 February 2010; in revised form: 20 April 2010 / Accepted: 22 April 2010 / Published: 23 April 2010
Show/Hide Abstract | Cited by 6 | PDF Full-text (1390 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
abstract graphic
p. 572-599
by  and
Pharmaceuticals 2010, 3(3), 572-599; doi:10.3390/ph3030572
Received: 28 January 2010; in revised form: 16 February 2010 / Accepted: 9 March 2010 / Published: 11 March 2010
Show/Hide Abstract | Cited by 9 | PDF Full-text (2001 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
p. 482-513
by
Pharmaceuticals 2010, 3(3), 482-513; doi:10.3390/ph3030482
Received: 12 January 2010; in revised form: 29 January 2010 / Accepted: 2 March 2010 / Published: 8 March 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (219 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
p. 433-440
by
Pharmaceuticals 2010, 3(2), 433-440; doi:10.3390/ph3020433
Received: 13 January 2010; in revised form: 23 January 2010 / Accepted: 3 February 2010 / Published: 5 February 2010
Show/Hide Abstract | PDF Full-text (103 KB) | HTML Full-text | XML Full-text
(This article belongs to the Special Issue Angiogenesis Inhibitors)
abstract graphic
Select/unselect all
Displaying article 1-8
Select articles Export citation of selected articles as:

Last update: 4 March 2014

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert